Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8300
+0.0300 (1.67%)
NASDAQ · Last Trade: Oct 16th, 3:24 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors